| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jiang Tianyi | Chief Executive Officer, Director | C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY | /s/ Brian Michael Brown, Attorney-in-Fact | 21 Oct 2025 | 0001865596 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVPT | Stock Option (Right to Buy) | Options Exercise | $0 | -570K | -10.09% | $0.00 | 5.08M | 13 Oct 2025 | Common Stock | 570K | $1.34 | Direct | F1 |
| transaction | AVPT | Stock Option (Right to Buy) | Options Exercise | $0 | -363K | -7.14% | $0.00 | 4.72M | 13 Oct 2025 | Common Stock | 363K | $1.59 | Direct | F1 |
| transaction | AVPT | Stock Option (Right to Buy) | Options Exercise | $0 | -1.72M | -36.39% | $0.00 | 3M | 13 Oct 2025 | Common Stock | 1.72M | $3.91 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The original Form 4, filed on October 15, 2025, is being amended by this Form 4 amendment to include these tranches on the list of options exercised by the Reporting Person in accordance with the 2016 Equity Incentive Plan. |